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Abstract
Introduction: High levels of reactive oxygen species (ROS) and impaired antioxidant defense systems lead to oxidative
stress (OxS) and tissue injury in different intestinal and extra intestinal conditions, including celiac disease (CD). The aim
of the present study was to investigate the role and potential use of ROS and other biomarkers of OxS in the clinical
management of CD.
Methods: We collected duodenal specimens and blood samples from naïve patients (N-CD), patients on a gluten free
diet (GFD) including responders (CD-GFD) and non-responders (NRCD).We measured plasmatic ROS production
(electron paramagnetic resonance, EPR), lipid peroxidation (thiobarbituric acid-reactive substances, TBARS), protein
oxidation (protein carbonyl, PC), total antioxidant capacity (TAC), nitric oxides and glutathione (GSH) in erythrocytes.
Results: Fifty-four patients affected by CD were enrolled (17 N-CD, 18 CD-GFD and 19 NRCD; 44 F; age 44 ± 13 years). A
signiﬁcant increase of plasmatic OxS biomarkers (ROS, peroxidated lipids, oxidized proteins, and nitrate concentrations)
and decrease of antioxidant species (TAC and GSH levels) were found in NRCD and N-CD compared to CD-GFD.
Comparably, a signiﬁcant direct relationship between the severity of duodenal atrophy, ROS production rates and
TBARS was found; conversely, TAC and GSH presented an inverse correlation.
Discussion: OxS is involved in CD tissue damage and correlates with the degree of duodenal atrophy. These ﬁndings
suggest the possible role of OxS biomarkers as indicators of CD activity during the clinical follow-up.
Introduction
High levels of reactive oxygen species (ROS) and/or
impaired antioxidant defense systems lead to oxidative
stress (OxS)1 and tissue injury2. ROS are produced in cells
during the metabolic pathways and they are potentially
very dangerous because of their high reactivity. In phy-
siological conditions the deleterious effects of ROS are
counteracted by the antioxidant defense systems, such as
non-enzymatic antioxidants (glutathione and vitamins)
and antioxidant enzymes (i.e., superoxide dismutase,
glutathione peroxidase/reductase). If the production of
ROS overwhelms the cellular antioxidant capacity, a
condition known as OxS occurs3.
OxS is implicated in the damage of cellular lipids,
proteins, and DNA, increased cellular swelling and
decreased cell membrane ﬂuidity. OxS plays an important
role in the pathogenesis of many human diseases4
including several gastrointestinal disorders5,6. In celiac
disease (CD), a chronic autoimmune enteropathy trig-
gered by gluten ingestion in genetically predisposed sub-
jects7, gluten promotes a Th1-driven autoimmune process
that leads to a duodenal mucosal atrophy8,9. Currently
the only effective treatment normalizing symptoms,
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autoantibodies (anti-transglutaminase type 2 IgA) and the
small bowel mucosa is a strict and chronic gluten-free diet
(GFD)10.
In most CD patients a clinical response is observed after
only a few weeks complying with a GFD treatment11.
Unfortunately, a complete clinical response and mucosal
recovery do not occur in all patients12. Indeed, a subgroup
of CD patients may have persistent or recurrent symptoms
(e.g., diarrhea and abdominal pain), inﬂammation of the
intestine and villous atrophy in spite of their GFD com-
pliance13. Non-responsive CD (NRCD) may be deﬁned as
the persistence of symptoms, signs, or laboratory abnorm-
alities typical of CD in spite of a 6–12 months long dietary
gluten avoidance. NRCD is common, affecting 7–30% of all
patients on GFD for CD14. There are many distinct etiol-
ogies, including unintentional gluten ingestion, other food
intolerances (i.e., lactose and fructose), small-intestinal
bacterial overgrowth, microscopic colitis, pancreatic insuf-
ﬁciency, irritable bowel syndrome, and refractory CD.
While the CD diagnostic criteria are well known and well
established, it remains difﬁcult to deﬁne a correct use of
available biomarkers during follow-up.
The molecular mechanisms underlying CD are still
unclear, but a recent in vitro study has shown that OxS is
implicated in the pathophysiology of the disease15–17.
Indeed, several investigations have shown that gluten
exposure can induce an intracellular oxidative imbalance
in CD patients, characterized by increased levels of lipid
peroxidation products and oxidized/reduced glutathione
ratio and decreased protein-bound sulfhydryl groups18.
Moreover, celiac patients have been found to express
signiﬁcantly inducible nitric oxide synthase in the intest-
inal wall, which results in signiﬁcantly increased levels of
nitric oxide (NO)19,20. High contents of NO metabolites
were also found in the plasma and serum of untreated CD
patient21,22.
The broad spectrum of clinical manifestations of CD
makes difﬁcult to assess the disease activity in patients on
a correct GFD by means of single measurements, while a
multidisciplinary approach would possibly generate more
meaningful outcome information.
In this regard, the ﬁrst aim of the study was to inves-
tigate the effects of OxS in CD, evaluating the levels of: (i)
ROS by using electron paramagnetic resonance (EPR)
technique, able to provide the direct detection of the
‘instantaneous’ presence of free radical species in the
sample;23,24 (ii) oxidative damage biomarkers detected by
enzymatic methods in the plasma of celiac patients.
Our secondary aim was to look for new plasma bio-
markers corresponding to morphological/functional
alterations assessed by histology in duodenal biopsies.
Furthermore, possible correlations between ROS pro-
duction, other biomarkers of OxS and hematological
parameters were also investigated.
Methods
Subjects
Duodenal endoscopic biopsies and peripheral blood
samples of celiac patients were analyzed. The diagnosis of
CD was made at the Center for Prevention and Diagnosis
of Celiac Disease of the Fondazione IRCCS Ca’ Granda
Ospedale Maggiore Policlinico in Milan (Italy) according
to the current international guidelines6. Oslo criteria for
CD nomenclature has been followed14. Fifty-four CD
patients was divided into three groups: Naïve celiac
patients (N-CD, n= 17), GFD-responsive patients (CD-
GFD, n= 18) and NRCD (n= 19). Furthermore, a control
group (CTR) was added in the evaluation of ROS pro-
duction rates, according to the value of ROS production
rate assessed in one hundred healthy middle-aged
sedentary subjects previously published24.
The investigation was approved by the local Ethics
Committee (Fondazione IRCCS Ca’ Granda Ospedale
Maggiore Policlinico n. 424bis 09/07/2014) and all the
patients involved in the study gave their written informed
consent.
Sample preparation
From each patient, at least 5 proximal small-intestinal
biopsy specimens, as well as peripheral blood samples,
were obtained. Endoscopic duodenal samples were rou-
tinely prepared for histopathological analysis as previously
described25. Venous blood samples were collected,
approximately 10 mL in heparinised, and 5mL in EDTA
vacutainer tubes, for the assessment of ROS, OxS bio-
markers, hematological parameters and NO metabolites.
Blood samples were taken in the morning, after at least 8-
hour fasting, by a cubital vein puncture. Hematological
values were determined using an automated hematology
analyzer (Automatic Beckman Coulter LH-750), accord-
ing to the standard laboratory procedures.
Parameters, such as hemoglobin (Hgb), hematocrit (Hct),
mean corpuscular volume (MCV), mean corpuscular
hemoglobin (MCH), mean corpuscular hemoglobin con-
centration (MCHC), red cell distribution width (RDW),
platelets and absolute leukocyte count were recorded.
For the quantiﬁcation of ROS production and OxS
biomarkers, the heparinized blood samples, and for NO
metabolites assessment, the EDTA blood samples, were
centrifuged at 1000xg for 10 min at 4 °C. The samples of
plasma and erythrocytes obtained were immediately
stored in multiple aliquots at −80 °C until assayed. The
samples were thawed only once before analysis, which was
carried out within 2 weeks from collection.
Electron paramagnetic resonance for reactive oxygen
species detection
All measurements were carried out by means of a X-
band EPR spectrometer (E-Scan-Bruker BioSpin, GmbH).
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For each recruited patient, the ROS production rate was
determined using a recently implemented EPR
method24,26. Brieﬂy: 50 μL of each plasma sample was
immediately treated with dissolved CMH (1-hydroxy-3-
methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine) probe
(1:1). 50 μL of the obtained solution was put in a glass EPR
capillary tube, in turn placed inside the cavity of the E-
scan spectrometer for data acquisition (microwave fre-
quency 9.652 GHz; modulation frequency 86 kHz; mod-
ulation amplitude 2.28 G; sweep width 60 G, microwave
power 21.90 mW, number of scans 10; receiver gain
3.17.101). The sample temperature was stabilized and kept
at 37 °C by the Temperature & Gas Controller “Bio III”
unit, interfaced to the spectrometer.
All data were converted in absolute concentration levels
(μmol· min−1) by adopting the CP (3-Carboxy-2,2,5,5-
tetramethyl-1-pyrrolidinyloxy) stable radical as the
external reference. The high reproducibility of the EPR
measurements was well demonstrated previously24.
HPLC analysis of erythrocytes glutathione
Total glutathione (GSH) was measured in erythrocytes
by high-performance liquid chromatography, as pre-
viously described27. Values are expressed in μmol· L−1.
Lipid peroxidation
Lipid peroxidation was measured in plasma spectro-
photometrically at 532 nm (Inﬁnite M200, Tecan) by
adopting the thiobarbituric acid-reactive substances
(TBARS) assay kit (Cayman Chemical).
A linear calibration curve was calculated from differently
concentrated pure malon-di-aldehyde (MDA) solutions.
Protein oxidation
A PC assay kit (Cayman Chemical) was used to color-
imetrically evaluate in plasma the oxidized protein
amount at 370 nm (Inﬁnite M200, Tecan). The obtained
values were normalized to the total protein concentration
in the ﬁnal pellet (280 nm), to take into account the
protein loss during the washing steps.
Antioxidant capacity
Total antioxidant capacity (TAC) levels (mM) in plasma
were estimated using Antioxidant Assay Kit (Cayman
Chemical) following the manufacturer’s protocol. A
Trolox standard curve was used to quantitate the anti-
oxidant capacity of the sample, measured in millimolar
Trolox equivalents at 750 nm (Inﬁnite M200, Tecan).
Nitric oxides metabolites in plasma
Plasma EDTA samples were ultra-ﬁltered through a 10
kDa molecular weight cut-off ﬁlter using an ultra-
centrifuge at 14,000 × g for 60 min at 4 °C to reduce
background absorbance due to the presence of
hemoglobin. The ultra-ﬁltered material was recovered
and used to measure nitrite and nitrate concentrations
using a commercial kit (Cayman Chemical). The samples
were read by adding Griess reagents in at 545 nm. A linear
calibration curve was computed from pure nitrite and
nitrate standard.
Statistical analysis
Statistical analysis was performed using GraphPad
Prism package (GraphPad Prism 7, GraphPad Software
Inc., San Diego, CA, USA).
For all parameters, descriptive statistics were calculated
and the normality of the distribution was checked by the
Shapiro-Wilk normality test. Data are presented as mean
± SD, 95% CI. Comparisons between experimental data
were analyzed using analysis of variance ANOVA with a
Bonferroni post-hoc test. Spearman’s correlation coefﬁ-
cient test (r, 95% conﬁdence interval (CI)) was used for
identifying relationships among selected parameters.
The diagnostic performance of individual assays was
evaluated using receiver operating characteristic (ROC)
curve analysis. A p < 0.05 value was considered statistically
signiﬁcant. The prospective power calculation to deter-
mine the signiﬁcant experimental number was made by
using the Freeware G*Power software (http://www.
psycho.uniduesseldorf.de/abteilungen/aap/gpower3/). At
a power of 80%, the calculated number of signiﬁcant
subjects was 11, well below the population of subjects
recruited for this study.
Results
Fifty-four CD patients (44 females; mean age 44 ± 13
years, range 19–80 years) were enrolled. In detail: 17 N-
CD, 18 CD-GFD, and 19 NRCD.
Demographic and hematologic results are reported in
Table 1. Age, gender, and GFD were not statistically dif-
ferent among the three groups. The investigated blood
parameters, excluding leukocyte and platelet counts, were
signiﬁcantly lower in N-CD and NRCD compared to CD-
GFD patients (p < 0.05).
As shown in Fig. 1A, plasmatic ROS production is sig-
niﬁcantly increased in N-CD (0.21 ± 0.03 μmol· min−1)
and NRCD (0.22 ± 0.04 μmol·min−1) patients compared
with CD-GFD (0.17 ± 0.03 μmol·min−1). Moreover, no
signiﬁcant difference was found between CD-GFD
and CTR (0.17 ± 0.03, vs 0.16 ± 0.02 μmol· min−1
respectively)24.
Plasmatic TAC levels were signiﬁcantly lower in the N-
CD and NRCD groups compared with CD-GFD (1.07 ±
0.30 mM vs 1.16 ± 0.47 mM vs 1.68 ± 0.54 mM in N-CD,
NRCD, and CD-GFD respectively) (Fig. 1B). Similarly,
GSH levels in erythrocytes were signiﬁcantly lower in the
N-CD and NRCD (Fig. 1C) compared with CD-GFD
(534.40 ± 37.46 μmol· L−1 vs 507.80 ± 81.73 μmol· L−1 vs
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634.00 ± 187.80 μmol· L−1 in N-CD, NRCD, and CD-GFD
respectively).
Oxidative damage in plasma was assessed by TBARS
and PC determination: Fig. 1D shows signiﬁcantly higher
values of TBARS in the N-CD and NRCD groups com-
pared to CD-GFD (3.59 ± 0.67 μM vs 3.46 ± 0.87 μM vs
2.82 ± 0.47 μM in N-CD, NRCD, and CD-GFD respec-
tively). Accumulation of PC (Fig. 1E) was signiﬁcantly
higher in the N-CD and NRCD compared to CD-GFD
(1.42 ± 0.43 nmol. mg−1 protein vs 1.23 ± 0.53 nmol. mg−1
protein vs 0.91 ± 0.20 nmol. mg−1 protein in N-CD,
NRCD, and CD-GFD respectively).
In Fig. 2 data of plasmatic nitrates concentrations
(NOx=NO2+NO3) are reported. Signiﬁcantly higher
values were recorded for the NRCD and N-CD compared
to CD-GFD (99.74 ± 30.76 μmol· L−1 vs 54.61 ± 14.57
μmol· L−1 vs 22.21 ± 6.92 μmol· L−1 in NRCD, N-CD,
and CD-GFD respectively) and a signiﬁcantly different
NOx concentration between N-CD and NR-CD was
recorded too.
The possible correlation between the classiﬁcation of
histologic ﬁndings in CD (Marsh grade), plasmatic ROS
production and OxS biomarkers was investigated for all
the groups (CD-GFD, N-CD, and NRCD) (Fig. 3).
A signiﬁcant direct relationship was found between the
Marsh score and ROS production rate (R2= 0.19; p <
0.0009), TBARS (R2= 0.19; p < 0.0001), and PC (R2=
0.16; p < 0.002) (Fig. 3A,D,E). Contrariwise, an inverse
correlation was found between the Marsh grade and TAC
(R2= 0.22; p < 0.0003) and GSH (R2= 0.34; p < 0.0001)
(Fig. 3B, C).
For all the three groups of patients, a correlation
between ROS production, GSH in erythrocytes and
TBARS concentrations was found (Fig. 4). A positive
relationship was found between ROS production and
TBARS concentration (R2= 0.36; p < 0.0001) (Fig. 4a),
while an inverse relationship was found with GSH con-
centration (R2= 0.27; p < 0.0001) (Fig. 4b). At high ROS
production rate levels corresponded greater TBARS
concentrations and lower GSH levels.
Moreover, a positive relationship was found between
TBARS concentrations and GSH levels (R2= 0.16;
p < 0.001) (Fig. 4C), as a correlation between OxS bio-
markers and hematological data for the N-CD and NRCD
groups (no correlation was found in CD-GFD group).
Table 2 reports the signiﬁcant correlation in both groups
of CD patents.
Finally, we analyzed the ROC curves of OxS markers to
discriminate duodenal atrophy (i.e., Marsh 3 lesions) and
of ROS to discriminate the different CD types (CD-GFD,
N-CD, and NRCD). ROS showed a good area under the
curve (>0.7) to discriminate atrophy and NRCD (see
supplementary ﬁgure 1).
Discussion
Our study demonstrates the impairment of oxidative
balance in CD patients, both treated and untreated, and
the potential use of OxS biomarkers in clinical practice
during follow-up. The main purpose of this study was to
describe the oxidative proﬁle of celiac patients, especially
of those not responding to GFD.
There is a growing number of studies in the literature
showing how ROS are involved in the pathology of
many diseases, including several gastrointestinal
disorders.
CD is an autoimmune gastrointestinal disorder caused
by gluten ingestion in genetically predisposed individuals
leading to an atrophy of the duodenal mucosa. Its clinical
presentation is heterogeneous and varies greatly with the
age of patients, duration, and intensity of the disease and
the possible presence of extra-intestinal disorders28.
Inﬂammation and OxS due to an increase of ROS and a
decrease of antioxidant defenses are involved in the
molecular mechanisms of CD18,29,30.
Table 1 Clinical, demographic, and biochemical
parameters of enrolled patients
N-CD CD-GFD NRCD
N (m/f) 17 (5/11) 18 (1/17) 19 (4/15)
Age (years) 38.8 ± 10.4 43.1 ± 10.2 49.3 ± 16.6
Marsh-Oberhuber score
0 0 13 0
1 0 5 0
2 0 0 2
3a 6 0 10
3b 8 0 2
3c 3 0 5
GFD duration (months) Not applicable 117 ± 84 86 ± 82
Leukocytes (199/L) 6.9 ± 1.6 6.3 ± 1.4 6.0 ± 1.2
Erythrocytes (1012/L) 4.2 ± 0.2 4.6 ± 0.6* 4.2 ± 0.3*
Hemoglobin Hb (g/dL) 12.8 ± 1.9 14.3 ± 1.1* 12.9 ± 1.1*
Hematocrit Hct (%) 38.6 ± 4.1 42.4 ± 4.3* 39.6 ± 2.4*
Corpuscular volume (fL) 82.7 ± 8.1 89.1 ± 6.4* 86.8 ± 7.1
MCH (pg) 28.1 ± 2.5 31.1 ± 1.7*** 29.4 ± 2.1*
MCHC (g/dL) 32.7 ± 1.5 33.9 ± 0.1* 32.8 ± 1.1*
RDW (%) 13.1 ± 1.2 14.7 ± 1.1*** 13.5 ± 1.2***
Platelets (109/L) 271.2 ± 66.8 281.5 ± 44.1 305.0 ± 54.7
Data expressed as mean ± SD.
CD celiac disease, GFD gluten free diet, MCH Mean corpuscular hemoglobin,
MCHC mean corpuscular hemoglobin concentration, N-CD naïve celiac patients,
CD-GFD GFD-responsive patients, NRCD non-responsive CD, RDW red blood cell
distribution width.
Signiﬁcant differences compared to N-CD: *p < 0.05, ***p < 0.001.
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Understanding the oxidative-inﬂammatory altered
condition that characterizes NRCD patients is a critical
achievement for the development of new medical (and
pharmacological) approaches.
Currently, physicians are unable with serological bio-
markers to distinguish patients with active or inactive CD
during GFD. As invasive techniques are still required to
differentiate between different forms of CD, the purpose
of the present analysis has been to evaluate the ability of
markers from peripheral blood to distinguish the various
CD subsets.
For the ﬁrst time, the present study shows a signiﬁcant
correlation between plasmatic ROS content, quantiﬁed
with EPR direct method, and the disease histological
grade (Marsh-Oberhuber) and type, especially NRCD, as
demonstrated by ROC.
No signiﬁcant difference was detected between celiac
patients and healthy controls in respect to age and gender.
In CD iron deﬁciency anemia is primarily a con-
sequence of the chronic mucosal damage and impair-
ment of absorption mechanisms in the small bowel, due
to the inﬂammatory process31–33. In our study hemo-
globin values in CD and NRCD were in the normal
range 12–15.6 g/dL, although there was a clear trend
towards mild anemia. According to the results, it clearly
appears that NRCD patients, in spite of the GFD ther-
apy, have a hematologic framework comparable to N-
CD patients, in whom the pathology was diagnosed for
the ﬁrst time.
The pathogenesis of CD has not been fully explained.
The imbalance of OxS was demonstrated in the patho-
mechanism of gastrointestinal diseases, in particularly for
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Fig. 1 Scatter plots of oxidative stress biomarkers. A ROS production rate (μmol· min−1) detected by EPR technique; B total antioxidant capacity (TAC,
mmol·equiv·Trolox/L); C total glutathione (GSH, μmol· L−1) concentrations in erythrocytes; D thiobarbituric acid-reactive substances (TBARS, μM); E
protein carbonyl (PC, nmol. mg−1 protein) in plasma of N-CD (n= 17, square symbol), CD-GFD (n= 18, circle symbol) and NRCD (n= 19, triangle symbol)
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± SD. Signiﬁcant differences: *p < 0.05; #p < 0.01
CD-GFD NCD NRCD
0
50
100
150
200
N
O
x 
(
m
ol
L-
1 )
#
#
Fig. 2 Scatter plots of the plasma nitrate concentration (μmol· L−1) in
N-CD (n= 17, square symbol), CD-GFD (n= 18, circle symbol), and
NRCD (n= 19, triangle symbol) patients. The results are expressed as
mean ± SD. Signiﬁcant differences: #p < 0.01 and §p < 0.001
Moretti et al. Clinical and Translational Gastroenterology  (2018) 9:157 Page 5 of 9
Ofﬁcial journal of the American College of Gastroenterology
0 1 2 3a 3b 3c
0.0
0.1
0.2
0.3
0.4
MARSH score
R
O
S 
pr
od
uc
tio
n 
ra
te
 (µ
m
ol
  
m
in
-1
) 
0 1 2 3a 3b 3c
0
2
4
6
MARSH score
TB
AR
S 
(µ
M
)
0 1 2 3a 3b 3c
0
1
2
3
MARSH score
An
tio
xi
da
nt
 C
ap
ac
ity
 (m
illi
M
ol
i T
ro
lo
x)
0 1 2 3a 3b 3c
0.0
0.5
1.0
1.5
2.0
2.5
MARSH score
PC
 (n
m
ol
 . 
m
g-
1  p
ro
te
in
)
0 1 2 3a 3b 3c
0
200
400
600
800
1000
MARSH score
G
SH
 to
ta
l (
µm
ol
  
L-
1 )
  
A B C
D E
Fig. 3 The relationship between the Marsh score and oxidative stress biomarkers. A ROS production rate (μmol· min−1), B TAC (mmol.equiv.Trolox.
L−1), C GSH (μmol·L−1), D TBARS (μM) and (E) PC (nmol. mg−1 protein) assessed in the plasma of N-CD (n= 17, white symbol), CD-GFD (n= 18, gray
symbol) and NRCD (n= 19, black symbol) patients. The linear regression ﬁt (solid line) is reported for each relationship
0.0 0.1 0.2 0.3 0.4
0
2
4
6
ROS production rate (µmol  min-1) 
TB
AR
S 
(µ
M
)
0 2 4 6
0
200
400
600
800
1000
TBARS (µM)
G
SH
 to
ta
l (
µm
ol
  
L-
1 )
  
0.0 0.1 0.2 0.3 0.4
0
200
400
600
800
1000
ROS production rate (µmol  min-1) 
G
SH
 to
ta
l (
µm
ol
  
L-
1 )
  
A B
C
Fig. 4 The relationship between selected oxidative stress biomarkers. A TBARS (μM), B GSH (μmol· L−1), and (C) between TBARS (μM) and GSH
(μmol· L−1) in the plasma of N-CD (n= 17, white symbol), CD-GFD (n= 18, gray symbol) and NRCD (n= 19, black symbol) patients. The linear regression
ﬁt (solid line) is reported for each relationship
Moretti et al. Clinical and Translational Gastroenterology  (2018) 9:157 Page 6 of 9
Ofﬁcial journal of the American College of Gastroenterology
CD in adults, and is also followed by an increased pro-
duction of ROS34 and reduced antioxidant protection.
Indeed Boda et al35. suggested that in patients with active
CD, gluten ingestion, along with the resulting inﬂamma-
tion, causes the activation of xantine oxidase in enter-
ocytes, which results in the overproduction of ROS and
further damage to the intestinal mucosa. Moreover the
results of various investigations suggest that gliadin dis-
turbs the pro-oxidant-antioxidant balance in the small-
intestinal mucosa of affected individuals through the
overproduction of ROS30,35.
In our study analyzing the plasma levels of ROS pro-
duction, a signiﬁcant increase in adult N-CD and NRCD
compared to CD-GFD patients was recorded. Signiﬁcant
decrease of the TAC levels in patients with naive CD
(35%) and celiac patients not responding to a GFD (25%)
as compared to celiac patients responder to GFD was
observed too. This indicates an inadequate physiological
response to a higher rate of production of ROS in active
celiac patients and especially in NRCD patients, for whom
the TAC is still compromised in spite of their GFD
regimen. The lower plasmatic TAC in N-CD and espe-
cially in NRCD patients is probably the result of a
malabsorption of dietary antioxidants due to the mucosal
damage. In agreement with this hypothesis other authors
have reported lower levels of antioxidants (retinol, α-
tocopherol, and ascorbic acid) in the plasma of patients
with active CD29,36.
The GSH redox cycle is the principal mechanism
of detoxifying lipid hydroperoxides in the intestine37.
High levels of cell GSH are preserved by de-novo synth-
esis, regeneration from glutathione disulﬁde, and in sev-
eral cell types, including enterocytes, by an import via
a Na+-dependent transport system38. Several in-vitro
studies have reported on the pro-oxidative effects of
gliadin in human intestinal cell cultures; Rivabene and
colleagues39 showed that the antiproliferative effect of
gliadin is associated with pro-oxidative changes, such as
the high level of lipid hydroperoxides, reduction of GSH
level and gradual disappearance of sulfhydryl groups in
proteins. Elli et al. demonstrated that gliadin causes a
reduction in the GSH content and a gliadin concentration-
related decrease in the activity of glutathione reductase,
glutathione peroxidase and GSH-S-transferase5.
Besides the intestinal mucosa, the erythrocytes are rich
in glutathione and glutathione-related enzymes. In our
study, a signiﬁcant lower (23%) GSH concentration was
found in the erythrocytes of N-CD and NRCD patients
compared to control subjects. The low concentration of
GSH in NRCD patients can be explained with the
assumption that there is a decrease in glutathione per-
oxidase and glutathione reductase activities such as
reported both in biopsies and erythrocytes from celiac
patients with severe villous atrophy40,41.
It is very interesting to note how GSH concentration is
also indirectly related to a clinical parameter such as
Marsh score. Furthermore, in CD patients the ROS pro-
duction resulted correlated positively with TBARS and
negatively with GSH levels as previously reported in
healthy subjects24,42. In this study for the ﬁrst time we
have demonstrated signiﬁcant correlations between the
histological grade (Marsh-Oberhuber) score and TAC
(Fig. 3B) GSH (Fig. 3C), ROS production (Fig. 3a) and
OxS biomarkers (TBARS: Fig. 3D; PC: Fig. 3E).
An increased plasma concentration of TBARS (23%)
indicating a not adequate anti-oxidative system in N-CD
and NRCD patients compared to CD-GFD subjects was
found. The data are in agreement with those reported by
Stojiljkovic et al43. on plasma lipid peroxidation bio-
markers in active celiac patients.
The increased lipid peroxidation of plasma chylomicrons
and low-density lipoproteins in a celiac patient has been
also reported44. It was shown that a high lipid hydroper-
oxides level causes single- and double-strand DNA breaks
as well as the oxidative damage of cell membranes45.
In our study, the increase of TBARS concentration
correlated with the reduction of the GSH content. Ele-
vated TBARS and the shift of the cellular pro-oxidant/
antioxidant balance, is reported affect cell proliferation,
differentiation or apoptotic responses and disrupt tissue
homeostasis37. This may, in part, explain the increased
risk of refractory CD and malignancy, observed in celiac
patients that do not respond to a GFD.
The PC content is the most general and widely used
marker of severe oxidative protein damage. In our study,
we have found a signiﬁcant increase: 51% in N-CD and
17% in NRCD patients compared to CD-GFD subjects.
Table 2 Relationships between the OxS biomarkers and
hematologic data of the patients affected by CD
R2 P
N-CD Hemoglobin vs TAC 0.22 0.05
Leukocytes 0.35 0.01
Erythrocytes 0.26 0.03
Hematocrit 0.27 0.03
Corpuscular volume 0.64 0.001
MCH 0.30 0.02
Hematocrit vs Hemoglobin 0.26 0.03
Corpuscular volume 0.29 0.02
MCH 0.30 0.02
NRCD Hemoglobin vs Corpuscular volume 0.44 0.002
MCHC 0.26 0.02
Hematocrit vs Total GSH 0.22 0.04
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The data are consistent with those reported by Odetti
et al29.
NO is a free radical gas, produced by the enzyme NO
synthase (NOS), that has a wide variety of physiological
and pathological roles in the gastrointestinal tract21,46.
NO is rapidly metabolized by erythrocytes into the stable
end-products nitrate and nitrite (NOx), which can be
easily measured21.
Some authors have noted increased levels of NOx in the
serum and urine of CD children, with a positive correla-
tion between the concentration of NOx and increased
concentration of iNOS in the small intestine19,47,48.
Murray et al. have showed that plasmatic NOx con-
centrations in adult patients with CD are higher than in
treated patients with GFD and those with other upper
gastrointestinal disorders21. The higher production of NO
metabolites and the consequent nitrosative stress pro-
mote the impairment of tight junctions in the small
intestine of CD patients, perhaps by down-regulating the
expression of zona-ocludens-149.
The results of our study, where NRCD patients exhibited
high levels of NOx compared to the control condition and
showed severe histologic changes too, are similar to data
reported previously21,22. Moreover, ROC analysis conﬁrmed
the usefullness fo ROS in discriminating the NRCD from the
responsovise CD wirg represents a diagnostic dillemma.
Conclusions
Our study investigated the possible correlations in all
the patient groups of OxS biomarkers with the Marsh-
score classiﬁed histologic ﬁndings in CD.
For the ﬁrst time we have shown how the increase in the
ROS production rate, assessed in the peripheral blood, is
in strict correlation with the severity of intestinal damage,
evaluated by histological analysis (Marsh score).
Moreover our results conﬁrm that OxS is strongly
associated with gluten-related disorders and an important
factor in the pathogenesis of CD so it may be an impor-
tant additional parameter for monitoring a gluten-related
disorder and for establishing the effectiveness of GFD.
Study Highlights
What is current knowledge
● Oxidative stress is involved in the damage of
cellular lipids, proteins and DNA, increased cellular
swelling and decreased cell membrane ﬂuidity
● Oxidative system imbalance plays a pivotal role in
the pathogenesis of different gastrointestinal
disorders.
● In celiac disease, an impairment of oxidative
balance has been demonstrated after gluten
exposure.
What is new here
● An alteration of oxidative stress biomarkers has
been found in naïve and non responsive celiac
patients compared to responsive patients.
● A signiﬁcant correlation between the severity of
duodenal atrophy and reactive oxygen species have
been found.
● The alterations of oxidative stress biomarkers and
their correlation with the intestinal damage could
be useful as indicators of celiac disease activity
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